Tag Directory / MERGERSANDACQUISITIONS     showing 1–4 of 4


for: Saturday, February 21, 2026



Novartis signs macrocyclic deal with Unnatural Products for $100M upfront / Endpoints

Kyle LaHucik / endpoints - Novartis will pay $100 million upfront to tap into a macrocyclic peptide platform from Unnatural Products, a deal that could lead to new cardiovascular disease medicines. The move allows the Swiss pharma giant to delve ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment


Saturday, February 21, 2026, 6:22 am / permalink 19517 / 2 stories in 18 days


Hims to buy Australia’s Eucalyptus for $240M upfront in global push / Endpoints

Ngai Yeung / endpoints - In a bid to build out its global presence, Hims is buying Australian digital health company Eucalyptus in a deal worth $240 million upfront. The deal announced Thursday morning would allow Hims to launch in ...

#healthcare #mergersandacquisitions #corporatetakeover #digitalhealth


Saturday, February 21, 2026, 1:23 am / permalink 19510 / 5 stories in 18 days


Prime Healthcare Foundation acquires Maine health system / Healthcare Dive

Sydney Halleman / healthcaredive - Nonprofit Prime Foundation, an affiliate of for-profit hospital operator Prime Healthcare, now owns 21 hospitals across eight states.

#healthcare #mergersandacquisitions #corporatetakeover


Saturday, February 21, 2026, 12:23 am / permalink 19504 / 3 stories in 18 days


Walgreens to lay off hundreds of employees / Healthcare Dive

Dani James / healthcaredive - The drugstore retailer said it was simplifying its organization to speed up decision-making in a move impacting at least 600 workers.

#healthcare #pharmaceuticals #mergersandacquisitions


Saturday, February 21, 2026, 12:23 am / permalink 19503 / 2 stories in 18 days


Back to Top


MERGERSANDACQUISITIONS Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.



More Top Stories...


FDA refuses to review Moderna mRNA flu vaccine application

Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making. More...


FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

AstraZeneca’s application to market its subcutaneous prefilled pen formulation of Saphnelo for treating lupus has hit a roadblock after the FDA issued a complete response letter. The decision delays the drug’s approval and raises questions about its future in the competitive immunotherapy market. More...


CMS proposes sweeping changes to ACA marketplace plan rules

CMS has proposed a major rule reshaping Affordable Care Act marketplace policies, including loosening limits on non-standard plan designs and promoting lower-premium options such as catastrophic coverage. The agency says the changes will reduce costs and boost flexibility, while critics warn they could increase confusion and weaken consumer protections—because shopping for insurance clearly wasn’t complicated enough. More...


Tenet forecasts major ACA exchange enrollment drop and financial hit

Tenet Healthcare is warning that the expiration of enhanced Affordable Care Act premium tax credits will drive a steep reduction in ACA exchange enrollment, projecting a significant revenue impact in 2026. Despite the headwind, the company says it expects earnings growth, leaning on acuity and operational performance—because nothing calms Wall Street like “we’ll make it up somewhere else.” More...


City of Hope promotes Nisha Morris to senior marketing chief

City of Hope named Nisha Morris as Senior Vice President and Chief Marketing and Communications Officer, adding marketing leadership to its executive team. The move signals a renewed focus on brand, outreach, and patient engagement as the cancer center sharpens its communication and growth strategies. More...



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.